mGluR5 Ligand, CDPPB
CAS: 781652-57-1
Ref. 3D-GGB65257
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
- 3-Cyano-N-(2,5-diphenyl-2H-pyrazol-3-yl)-benzamide
- 3-Cyano-N-(2,5-diphenylpyrazol-3-yl)benzamide
- Benzamide, 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)-
- Cdppb
CDPPB is a potent, selective, and orally active mGluR5 ligand. It has been shown to inhibit the activation of cell signaling pathways that are involved in dopamine release and glutamate-mediated synaptic transmission. CDPPB is characterized by allosteric activity, which means that it binds to the metabotropic glutamate receptor (mGluR) and alters its function. This drug also inhibits protein synthesis and increases locomotor activity in mice. CDPPB has been studied as a possible treatment for skin cancer and may have therapeutic potential for other diseases of the central nervous system such as Parkinson's disease.
Propriedades químicas
Consulta técnica sobre: 3D-GGB65257 mGluR5 Ligand, CDPPB
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
